C2i Genomics logo

C2i Genomics

C2i Genomics is now part of Veracyte. We encourage you to follow Veracyte on LinkedIn.

26 employees · est. 2019 · New York, United States

VS
HalioDx logo

HalioDx

Veracyte helps doctors make better cancer and disease diagnoses with immuno-oncology diagnostic technologies, including Immunoscore®.

51-200 employees · est. 2014 · Marseille, France

HalioDx is the older company (2019 vs 2014); HalioDx is the larger of the two.

Side-by-Side Comparison

C2i Genomics HalioDx
Founded
2019 2014 older
Headquarters
New York, United States Marseille, France
Employees
26 51-200 larger
Industry
Health Care, Health and Wellness Health Care, Pharmaceutical
Funding Stage
Series B Series B
Total Funding
$112.00M $26.50M
Funding Rounds
2 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
C2i Genomics, Veracyte, Genomics, Medical Diagnostics, Cancer Diagnosis, Acquisition, LinkedIn, Health Technology, Mergers And Acquisitions Diagnostics, Oncology, Immuno-oncology, Precision Medicine, Cancer Diagnosis, Biomarker Development, Immunoscore®, Clinical Decision Support, Biopharma Collaborations, Immune Contexture Analysis
Website
c2i-genomics.com haliodx.com
C2i Genomics logo

About C2i Genomics

C2i Genomics is a company in the Health Care industry, founded in 2019 and headquartered in the United States. The company recently received a $100.00M Series B investment on April 15, 2021, with participation from notable investors including LionBird, Casdin Capital, iGlobe Partners, Driehaus Capit...

HalioDx logo

About HalioDx

HalioDx is a global diagnostics company that focuses on improving patient care through its immuno-oncology diagnostic technologies and services. Formerly known as HalioDx, the company operates in the Health Care and Pharmaceutical sectors and is headquartered in France. One of their flagship offerin...

We will tell you when either one moves

BounceWatch watches C2i Genomics and HalioDx for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at C2i Genomics and HalioDx — by email.

Frequently Asked Questions

C2i Genomics — C2i Genomics is now part of Veracyte. We encourage you to follow Veracyte on LinkedIn.. HalioDx — Veracyte helps doctors make better cancer and disease diagnoses with immuno-oncology diagnostic technologies, including Immunoscore®.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
C2i Genomics has raised $112.00M while HalioDx has raised $26.50M.
C2i Genomics and HalioDx operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare C2i Genomics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at C2i Genomics on 12 Sep 2024, and HalioDx on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy